IPSEN - stock earnings

IPN.PA Quarterly earnings

DateEarningsRevenue
2023Q4 449.2 million EUR 1.6 billion EUR
2023Q2 195.1 million EUR 1.6 billion EUR
2022Q4 253.2 million EUR 1.7 billion EUR
2022Q2 394.3 million EUR 1.5 billion EUR
2021Q4 343.4 million EUR 1.6 billion EUR
2021Q2 303.3 million EUR 1.4 billion EUR
2020Q4 326.2 million EUR 671.5 million EUR
2020Q2 136.6 million EUR 671.5 million EUR
2020Q1 136.6 million EUR 671.5 million EUR
2019Q4 -14.6 million EUR 673.2 million EUR
2019Q3 -14.6 million EUR 673.2 million EUR
2019Q2 -14.6 million EUR 673.2 million EUR
2019Q1 -14.6 million EUR 673.2 million EUR
2018Q4 96.5 million EUR 587.1 million EUR
2018Q3 96.5 million EUR 587.1 million EUR
2018Q2 98.8 million EUR 562.6 million EUR
2018Q1 96.5 million EUR 587.1 million EUR
2017Q4 67.3 million EUR 502.9 million EUR
2017Q3 67.3 million EUR 502.9 million EUR
2017Q2 63.0 million EUR 484.9 million EUR
2017Q1 67.3 million EUR 502.9 million EUR
2016Q4 56.1 million EUR 417.8 million EUR
2016Q3 56.1 million EUR 417.8 million EUR
2016Q2 ? EUR 403.3 million EUR
2016Q1 56.1 million EUR 417.8 million EUR
2015Q4 46.9 million EUR 380.1 million EUR
2015Q3 46.9 million EUR 380.1 million EUR
2015Q2 ? EUR 376.0 million EUR
2015Q1 46.9 million EUR 380.1 million EUR
2014Q4 38.1 million EUR 333.1 million EUR
2014Q3 38.1 million EUR 333.1 million EUR
2014Q2 ? EUR 332.6 million EUR
2014Q1 38.1 million EUR 333.1 million EUR
2013Q4 35.6 million EUR 320.4 million EUR
2013Q3 35.6 million EUR 320.4 million EUR
2013Q2 ? EUR 332.0 million EUR
2013Q1 35.6 million EUR 320.4 million EUR
2012Q4 24.0 million EUR 319.4 million EUR
2012Q3 24.0 million EUR 319.4 million EUR
2012Q2 24.0 million EUR 319.4 million EUR
2012Q1 24.0 million EUR 319.4 million EUR
2011Q4 13.7 million EUR 308.7 million EUR
2011Q3 13.7 million EUR 308.7 million EUR
2011Q2 13.7 million EUR 308.7 million EUR
2011Q1 13.7 million EUR 308.7 million EUR
2010Q4 27.1 million EUR 292.6 million EUR
2010Q3 27.1 million EUR 292.6 million EUR
2010Q2 ? EUR 292.8 million EUR
2010Q1 27.1 million EUR 292.6 million EUR
2009Q4 39.2 million EUR 278.1 million EUR
2009Q3 39.2 million EUR 278.1 million EUR
2009Q2 39.2 million EUR 278.1 million EUR
2009Q1 39.2 million EUR 278.1 million EUR
2008Q4 37.0 million EUR 259.5 million EUR
2008Q3 37.0 million EUR 259.5 million EUR
2008Q2 37.0 million EUR 259.5 million EUR
2008Q1 37.0 million EUR 259.5 million EUR
2007Q4 38.1 million EUR 248.4 million EUR
2007Q3 38.1 million EUR 248.4 million EUR
2007Q2 38.1 million EUR 248.4 million EUR
2007Q1 38.1 million EUR 248.4 million EUR
2006Q4 36.2 million EUR 215.4 million EUR
2006Q3 36.2 million EUR 215.4 million EUR
2006Q2 36.2 million EUR 215.4 million EUR
2006Q1 36.2 million EUR 215.4 million EUR
2005Q4 30.6 million EUR 197.2 million EUR
2005Q3 30.6 million EUR 197.2 million EUR
2005Q2 30.6 million EUR 197.2 million EUR
2005Q1 30.6 million EUR 197.2 million EUR
2004Q4 18.9 million EUR 181.0 million EUR
2004Q3 18.9 million EUR 181.0 million EUR
2004Q2 18.9 million EUR 181.0 million EUR
2004Q1 18.9 million EUR 181.0 million EUR

IPN.PA Yearly earnings

DateEarningsRevenue
2023 644.4 million EUR 3.1 billion EUR
2022 648.6 million EUR 3.2 billion EUR
2021 646.6 million EUR 3.0 billion EUR
2020 548.0 million EUR 2.7 billion EUR
2019 -58.3 million EUR 2.7 billion EUR
2018 389.5 million EUR 2.3 billion EUR
2017 272.3 million EUR 2.0 billion EUR
2016 225.9 million EUR 1.7 billion EUR
2015 189.9 million EUR 1.5 billion EUR
2014 153.5 million EUR 1.3 billion EUR
2013 152.5 million EUR 1.3 billion EUR
2012 -29.5 million EUR 1.3 billion EUR
2011 424000 EUR 1.2 billion EUR
2010 95.7 million EUR 1.2 billion EUR
2009 157.2 million EUR 1.1 billion EUR
2008 147.7 million EUR 1.0 billion EUR
2007 151.1 million EUR 993.8 million EUR
2006 144.0 million EUR 861.7 million EUR
2005 119.2 million EUR 788.7 million EUR
2004 83.0 million EUR 724.0 million EUR
2003 101.4 million EUR 737.2 million EUR
2002 73.7 million EUR 697.8 million EUR

IPN.PA

Price: €120.80

52 week price:
99.70
130.70

Dividend Yield: 0.01%

5-year range yield:
0.01%
1.43%

Forward Dividend Yield: 0.99%

Payout Ratio: 16.22%

Payout Ratio Range:
12.68%
24.54%

Dividend Per Share: 1.20 EUR

Earnings Per Share: 7.41 EUR

P/E Ratio: 21.04

Exchange: PAR

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 10.0 billion

Average Dividend Frequency: 1

Years Paying Dividends: 19

Links: